NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/18/2022
Back to search
Official data from USPTO
REQMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/18/2022
Trademark type
Combined
Nice classes
35, 36, 42
Filing date
09/02/1998
Registration date
11/13/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2022
Last transaction
03/18/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
1998-05-00
First use in commerce
2000-04-00
Drawing code
5
Owner type
03
Owner location
Tokyo, JP
Examiner
KELLY, JOHN
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ReqMed Company, Ltd.
ReqMed Company, Ltd.
Representatives
Meredith D. Pikser Reed Smith LLP
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Clerical services for export and import agencies
Class 36
equity or research financial investment in the field of pharmaceutical venture companies in the U.S. to facilitate product development
Class 42
medical testing medical researchinspection of medicinesproviding medical informationproviding information about medicinesdiagnostic preparations and pre-clinical compounds to assist in licensing-out activities of promising pre-clinical compounds and act as an intermediary between US and Japanese pharmaceutical companies; providing research information on pre-clinical compounds for new drugs; co-development of candidate compounds for new drugs for others; medical and pharmaceutical research and development consulting services
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/18/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/18/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/09/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/13/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/22/2011
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/22/2011
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
11/22/2011
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
11/22/2011
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
11/11/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
11/11/2011
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/16/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
11/09/2007
E815
TEAS SECTION 8 & 15 RECEIVED
11/09/2007
CFIT
CASE FILE IN TICRS
01/16/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/31/2001
DOCK
ASSIGNED TO EXAMINER
07/02/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/29/2001
IUAF
USE AMENDMENT FILED
05/23/2001
EX1G
SOU EXTENSION 1 GRANTED
01/19/2001
EXT1
SOU EXTENSION 1 FILED
11/22/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/23/2000
PUBO
PUBLISHED FOR OPPOSITION
02/29/2000
NPUB
NOTICE OF PUBLICATION
01/28/2000
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/1999
CNEA
EXAMINER'S AMENDMENT MAILED
11/02/1999
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/1999
CNRT
NON-FINAL ACTION MAILED
04/08/1999
DOCK
ASSIGNED TO EXAMINER
03/26/1999
Continuous trademark protection
Get notified about every new filing that threatens REQMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.